SL BIO and Horizon Space Merger Approved by SEC

SL BIO and Horizon Space Acquisition II Corp. announced that the registration statement on Form F-4, in connection with HSPT's previously announced proposed business combination with SL Bio, has been declared effective by the U.S. Securities and Exchange Commission on January 13. The declaration of effectiveness by the SEC and the filing of the definitive proxy statement is an important step towards SL Bio becoming a publicly traded company. Upon closing of the Business Combination and related transactions, SL Science Holding Limited, a newly formed Cayman Islands exempted company and the post-business combination holding company, is expected to be listed on The Nasdaq Stock Market under the ticker symbol "SLBT." HSPT will hold an extraordinary general meeting of shareholders at 9:00 a.m. Eastern time on February 3, to approve the Proposed Transactions. The accompanying proxy statement/prospectus dated January 13, was first being mailed to shareholders on or about January 13. The closing of the Proposed Transactions will be subject to listing approvals by Nasdaq, approval by the shareholders of HSPT, and satisfaction or waiver, as applicable, of other customary closing conditions.